Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,847 Skin Cancer
clinical trials

Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Emory University/Winship Cancer Institute
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Hackensack University Medical Center
1285
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Indiana University Melvin and Bren Simon Center
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
University of Iowa Hospitals and Clinics
429
mi
from
Iowa City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Saint Louis University Cancer Center
415
mi
from
St. Louis, MO
Click here to add this to my saved trials
Benign and Malignant Skin Neoplasms Clinical Trial
A Study of Ultrasonography With Elastography in Skin Neoplasms
Status: Enrolling
Updated: 12/10/2010
Wayne State University
810
mi
from
18100 Oakwood Blvd Dearborn, MI
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology Clinical Trial
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Melanoma Clinical Trial
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbitl-Ingram Cancer Center
619
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
SCRI Tissue Testing Registry
Status: Enrolling
Updated: 1/31/2013
Tennessee Oncology, PLLC
558
mi
from
Nashville, TN
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
University of Colorado Cancer Center - Anschutz Cancer Pavilion
402
mi
from
Aurora, CO
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
UT Southwestern Medical Center at Dallas
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
Ochsner Cancer Institute
694
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Electronic Brachytherapy for the Treatment of NMSC
Status: Enrolling
Updated: 7/17/2015
Parkridge Medical Center - Sara Cannon Cancer Center
722
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)
Status: Enrolling
Updated: 6/28/2012
OHSU Knight Cancer Institute
1384
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
Status: Enrolling
Updated: 3/11/2013
Virginia Commonwealth University Massey Cancer Center
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
Barbara Ann Karmanos Cancer Institute
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
University of Michigan Comprehensive Cancer Center
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
Rush University Medical Center
608
mi
from
Chicago, IL
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
MSMC Research Program
1323
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Melanoma Clinical Trial
Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma
Status: Enrolling, Phase II
Updated: 1/28/2016
Comprehensive Cancer Centers of Nevada
970
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Status: Enrolling, Phase I
Updated: 12/31/1969
Vanderbilt University Medical Center
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Status: Enrolling, Phase I
Updated: 12/31/1969
M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Status: Enrolling
Updated: 6/24/2013
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
1114
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Status: Enrolling
Updated: 6/24/2013
Sky Ridge Medical Center
401
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Dinaciclib in Treating Patients With Advanced Melanoma
Status: Enrolling
Updated: 1/15/2013
Dana-Farber / Harvard Cancer Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of BMS-936558 vs. Dacarbazine in Untreated, Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/19/2013
Ppd
1109
mi
from
Richmond, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center SC-2
810
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I, II
Updated: 12/31/1969
USC Norris Oncology/Hematology-Newport Beach
1161
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
The Johns Hopkins University School of Medicine Johns Hopkins University
1151
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Stony Brook Internists PC
1334
mi
from
East Setauket, NY
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Swedish Cancer Institute Swedish Neuroscience Institute
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Endocrine Associates of Long Island, PC
1327
mi
from
Smithtown, NY
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Harbor-UCLA Medical Center Center for Men's Health
1178
mi
from
Torrance, CA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients
Status: Enrolling, Phase I, II
Updated: 2/29/2016
James Graham Brown Cancer Center
657
mi
from
Louisville, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Avera Medical Group Oncology and Hematology Aberdeen
534
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Community Clinical Research Center
671
mi
from
Anderson, IN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Community Hospital of Anderson and Madison County, Inc.
671
mi
from
Anderson, IN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
University of Michigan Health System
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Lifebridge Health
1145
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Florida Hospital Memorial Medical Center
1130
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
NorthShore University Health System
612
mi
from
Evanston, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Wheaton Franciscan Healthcare - Reiman Cancer Care
566
mi
from
Franklin, WI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
C.R. Wood Cancer Center at Glens Falls Hospital
1321
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Luke's Cancer Institute - Liberty
210
mi
from
Liberty, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Mercy Medical Center - North Iowa
444
mi
from
Mason City, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Methodist Estabrook Cancer Center
260
mi
from
Omaha, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Luke's Cancer Instititue - South
186
mi
from
Overland Park, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
Status: Enrolling, Phase I
Updated: 1/27/2015
University of Illinois at Chicago
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Biomarker Correlates of Hypoxia in Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 3/25/2016
H. Lee Moffitt Cancer Center & Research Institute
1112
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 10/28/2015
Wake Forest Baptist Health
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
Grand Rapids Clinical Oncology
733
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
Siouxland Hematology-Oncology Associates, LLP
336
mi
from
Sioux City, IA
Click here to add this to my saved trials
Stage III (Unresectable) or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab to Treat Melanoma
Status: Enrolling
Updated: 5/31/2016
Winship Cancer Institute
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Stage III (Unresectable) or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab to Treat Melanoma
Status: Enrolling
Updated: 5/31/2016
St. Luke's Hospital
1214
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Stage III (Unresectable) or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab to Treat Melanoma
Status: Enrolling
Updated: 5/31/2016
Mid Ohio Oncology Hematology, Inc.
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Status: Enrolling, Phase I, II
Updated: 2/29/2016
James Graham Brown Cancer Center
657
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma
Status: Enrolling, Phase I
Updated: 9/6/2013
Seattle Cancer Care Alliance
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma
Status: Enrolling, Phase I
Updated: 9/6/2013
UCLA
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Status: Enrolling, Phase I
Updated: 6/22/2016
Texas Oncology - Dallas
348
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory Children's Healthcare of Atlanta
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Children's Hospital
572
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists
Status: Enrolling, Phase I, II
Updated: 1/25/2018
M.D.Anderson Cancer Center
558
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Harrison Medical Center
1422
mi
from
Bremerton, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Arkansas for Medical Sciences
370
mi
from
Little Rock, AR
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Pacific Gynecology Specialists
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Aberdeen
1462
mi
from
Aberdeen, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Community Hospital of Anaconda
968
mi
from
Anaconda, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Mission Hospital-Memorial Campus
857
mi
from
Asheville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Colorado Hospital
400
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Sinai Comprehensive Cancer Center, Aventura
1315
mi
from
Aventura, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Greater Baltimore Medical Center
1147
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC-Heritage Valley Health System Beaver
957
mi
from
Beaver, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Bellflower
1165
mi
from
Bellflower, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth Saint Joseph Medical Center
1444
mi
from
Bellingham, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Strecker Cancer Center-Belpre
881
mi
from
Belpre, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Vincent Healthcare
780
mi
from
Billings, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alabama at Birmingham Cancer Center
684
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Medical Center
511
mi
from
Bloomington, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Boise
1040
mi
from
Boise, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Boulder
427
mi
from
Boulder, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Lafayette Family Cancer Center-EMMC
1575
mi
from
Brewer, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Southeast Cancer Center
454
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Carthage
403
mi
from
Carthage, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Sandra L. Maxwell Cancer Center
837
mi
from
Cedar City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Christiana Care Health System-Concord Health Center
1200
mi
from
Chadds Ford, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Chanute
129
mi
from
Chanute, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Carolina Surgical Clinic of Charlotte PA
959
mi
from
Charlotte, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Cheyenne Regional Medical Center-West
440
mi
from
Cheyenne, WY
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Good Samaritan Hospital - Cincinnati
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology and Hematology Care Inc - Blue Ash
734
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology Hematology Care Inc-Mercy West
720
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology Hematology Care Inc-Eden Park
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
1 … 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 … 68